Canaccord Genuity Reiterates a 'Buy' TranS1 Inc (TSON); Positive AMA Coding Panel Decision; Level I Code Imminent

March 5, 2012 9:56 AM EST
Get Alerts TSON Hot Sheet
Price: $2.06 --0%

Rating Summary:
    6 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 6 | Down: 4 | New: 55
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' TranS1 Inc (NASDAQ: TSON) price target raised from $3.50 to $5.50.

Analyst, William J. Plovanic, said, "We reiterate our rating on TranS1 following the announcement that the American Medical Association (AMA) Coding Committee has voted in favor of upgrading the company’s CPT codes to category I status from category III. We believe this marks a significant catalyst for the stock as it is the first major step toward turning on Medicare payments for physicians for AxiaLIF procedures. While Medicare reimbursement does not go live until January 1, 2013, and a dollar amount still needs to be ascribed to the code, we believe investors will view this positively as it present significant upside in the out years."

For an analyst ratings summary and ratings history on TranS1 Inc click here. For more ratings news on TranS1 Inc click here.

Shares of TranS1 Inc closed at $3.28 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst PT Change